ONCY - Oncolytics Biotech - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ONCY is currently covered by 1 analysts with an average price target of $4.67. This is a potential upside of $3.42 (273.6%) from yesterday's end of day stock price of $1.25.

Oncolytics Biotech's activity chart (see below) currently has 6 price targets and 17 ratings on display. The stock rating distribution of ONCY is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for ONCY is $5, Lowest price target is $5, average price target is $5.

Most recent stock forecast was given by PATRICK TRUCCHIO from HC WAINWRIGHT on 21-May-2025. First documented stock forecast 17-Feb-2021.

Best performing analysts who are covering ONCY - Oncolytics Biotech:

John Newman Patrick Trucchio

Currently out of the existing stock ratings of ONCY, 11 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$5

$3.82 (323.73%)

$5

1 months 25 days ago
(21-May-2025)

0/9 (0%)

$4.58 (1090.48%)

Buy

$5

$3.82 (323.73%)

$5

2 years 23 days ago
(23-Jun-2023)

0/3 (0%)

$2.26 (82.48%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ONCY (Oncolytics Biotech) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on ONCY (Oncolytics Biotech) with a proven track record?

JOHN NEWMAN

Which analyst has the current lower performing score on ONCY (Oncolytics Biotech) with a proven track record?

PATRICK TRUCCHIO

Which analyst has the most public recommendations on ONCY (Oncolytics Biotech)?

John Newman works at CANACCORD and has 5 price targets and 4 ratings on ONCY

Which analyst is the currently most bullish on ONCY (Oncolytics Biotech)?

Patrick Trucchio with highest potential upside - $3.82

Which analyst is the currently most reserved on ONCY (Oncolytics Biotech)?

John Newman with lowest potential downside - $3.82

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?